InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,210.00
(
0.18%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.75
(
0.67%
)
Bitcoin
61,339.80
(
-0.76%
)
Post# of 32755
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Mean Weimaraner

Send PM Follow Ignore
Followers 377
Posts 18026
Boards Moderated 3
Alias Born 04/29/2015

Mean Weimaraner

Re: Mean Weimaraner post# 452

Saturday, 01/26/2019 2:07:34 PM

Saturday, January 26, 2019 2:07:34 PM

Post# of 32755
The Company is now in the process of preparing for initial clinical trials that will most likely occur at multiple medical centers in Europe.
Patent-pending technology has allowed for the development of a medical device that can be implanted using a minimally invasive procedure. Once implanted via what will probably be a same-day surgery procedure, patients may not have to undergo surgery again using this treatment method.
Cerebain has a manufacturing agreement with Sonos Medical, a trusted and reliable medical device supplier.

http://www.cerebain.com/technology/

© 2013-2019 Cerebain Biotech. All rights reserved. | Design by Egreen Web Services LLC
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up